COVID-19 patients have a reduction in absolute numbers of lymphocytes, including CD4+ and CD8+ T lymphocytes, which display markers related to activation or exhaustion/senescence, along with altered expression of master regulators and several chemokine receptors [10,11,12]. The gene discussed is CD8A; the disease is COVID-19.